InsidersTradesSigma
Follow the PARADIGM BIOPHARMACEUTICALS LIMITED.. share price and the full management transaction log of the company, a listed issuer based in Australia. Shares trade on the AU market, under the oversight of ASX. Market capitalisation: €78k. All data is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
PARADIGM BIOPHARMACEUTICALS LIMITED is an Australian biopharmaceutical company focused on developing treatments for serious diseases. It is listed on the Australian Securities Exchange under the ticker PAR.